We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 03, 2020

Intensified Neoadjuvant Treatment With Interdigitating Radiotherapy and FOLFOX in Patients With Locally Advanced Rectal Cancer

Radiotherapy and Oncology

 

Additional Info

Radiotherapy and Oncology
Results of Phase II Trial of Intensified Neoadjuvant Treatment With Interdigitating Radiotherapy and Chemotherapy With Oxaliplatin, 5-Fluorouracil and Folinic Acid in Patients With Locally Advanced Rectal Cancer (PROARCT Trial)
Radiother Oncol 2020 Oct 13;[EPub Ahead of Print], S Ping Ng, J Chu, S Chander, M Bressel, J McKendrick, R Wong, M Steel, WK Murray, T Leong, A Heriot, M Michael, SY Ngan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading